首页> 外文期刊>Asian Journal of Chemistry: An International Quarterly Research Journal of Chemistry >Preparation of Ginkgolide B Polybutylcyanoacrylate Nanoparticles Suspension Powder-Injection
【24h】

Preparation of Ginkgolide B Polybutylcyanoacrylate Nanoparticles Suspension Powder-Injection

机译:银杏内酯B聚氰基丙烯酸丁酯纳米颗粒悬浮粉剂的制备

获取原文
获取原文并翻译 | 示例

摘要

Ginkgolide B polybutylcyanoacrylate nanoparticles suspension suspension were prepared using polybutylcyanoacrylate as drug carrier by interface polycondensation method and the trehalose was selected as cryoproctant in forming the powder injection. The result showed that the encapsulation efficiency and the drug loading of the drug nanoparticles suspension were 96.74 ± 1.25 % and 5.74 ± 0.46 % respectively and the powder injection of the ginkgolide B polybutylcyanoacrylate nanoparticles suspension exhibited good appearance, re-dispersion and high stability at the room temperature. The high loading of ginkgolide B polybutylcyanoacrylate in nanoparticles suspension might successfully solve the insolubility of ginkgolide B in aqua solution and be possible used as a brain targeted candidate drug form.
机译:以聚氰基丙烯酸丁酯为药物载体,通过界面缩聚法制备了银杏内酯B型聚氰基丙烯酸丙烯酸酯纳米颗粒悬浮液,并选择海藻糖作为冷冻助剂形成粉末注射剂。结果表明,该药物纳米粒悬浮液的包封率和载药量分别为96.74±1.25%和5.74±0.46%,银杏内酯B聚丁基氰基丙烯酸酯纳米粒悬浮液的粉末注射剂具有良好的外观,再分散性和高稳定性。室内温度。银杏内酯B聚氰基丙烯酸丙烯酸酯在纳米颗粒悬浮液中的高负载量可能成功解决银杏内酯B在水溶液中的不溶性,并有可能用作脑靶向候选药物形式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号